Fasciola hepatica infection: Clinical and computerized tomographic findings of ten patients

Turkish Journal of Gastroenterology

Volumn 17, Issue 1, 2006, Pages 40-45

  Yazgan Aksoy, Duygu ^a,c   Kerimoǧlu, Ülkü ^a   Oto, Aytekin ^b   Ergüven, Sibel ^a   Arslan, Serap ^a   Ünal, Serhat ^a   Batman, Figen ^a   Bayraktar, Yusuf ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NONE   (Turkey)

Author keywords

Computerized tomography; Fasciola hepatica; HIV; Liver infection; Tuberculosis

Indexed keywords

BITHIONOL; TRICLABENDAZOLE;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FASCIOLIASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MALE; SEROLOGY; SYMPTOMATOLOGY; TREATMENT RESPONSE; TUBERCULOSIS;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANTIPLATYHELMINTIC AGENTS; BITHIONOL; FASCIOLIASIS; FEMALE; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34047230264     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. nd ed. New York: McGraw-Hill, 1990; 473-89.
2. Hughes DL. Trematodes, excluding schistosomes with special emphasis on Fasciola. Curr Top Microbiol Immunol 1985; 120: 241-60.
3. Mas-Coma MS, Esteban JG, Bargues MD. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 1999; 77: 340-6.
4. Norton RA, Monroe L. Infection by Fasciola hepatica acquired in California. Gastroenterology 1961; 41: 46-8.
5. Hadden JW, Pascarelli EF. Diagnosis and treatment of human fascioliasis. JAMA 1967; 202: 149-51.
6. Schiappacasse RH, Mohammadi D, Christie AJ. Successful treatment of severe infection with Fasciola hepatica with praziquantel. J Infec Dis 1985; 152: 1339-40.
7. Wong RK, Pura DA, Mutter ML, et al. Hemobilia and liver flukes in a patient from Thailand. Gastroenterology 1985; 88: 1958-63.
8. Jones EA, Kay JM, Milligan HP, Owens D. Massive infection with Fasciola hepatica in man. Am J Med 1977; 63: 836-42.
9. Demirci M, Korkmaz M, Kaya S, Kuman A. Fascioliasis in eosinophilic patients in the Isparta region of Turkey. Infection 2003; 31: 15-8.
10. Saba R, Korkmaz M, Inan D, et al. Human fascioliasis. Clin Microb Infec 2004; 10: 385-7.
11. Espino AM, Dumenigo BE, Fernandez R, Finlay CM. Immunodiagnosis of human fascioliasis by enzyme-linked immunosorbent assay using excretory- secretory products. Am J Trop Med Hyg 1987; 37: 605-8.
12. Rivera-Marero CA, Santiago N, Hillyer GV. Evaluation of immunodiagnositic antigens in the excretory-secretory products of Fasciola hepatica. J Parasitol 1988; 74: 646-52.
13. Kabaalioǧlu A, Çubuk M, Şenol U, et al. Fascioliasis: US, CT and MRI findings with new observations. Abdom Imaging 2000; 25: 400-4.
14. Bassily S, Iskander M, Youssef FG, et al. Sonography in diagnosis of fascioliasis. Lancet 1989; 1: 1270-1.
15. Isseroff H, Sawma JT, Reino D. Fascioliasis: role of proline in bile duct hyperplasia. Science 1977; 198: 1157-9.
16. Pagola Serrano MA, Vega A, Ortega E, Gonzales A. Computed tomography of hepatic fascioliasis. J Comput Assist Tomog 1987; 11: 269-72.
17. Van Beers B, Pringot J, Guebel A, et al. Hepatobiliary fascioliasis: noninvasive imaging findings. Radiology 1990; 174: 809-10.
18. Foster JR. A study of the initiation of biliary hyperplasia in rats infected with Fasciola hepatica. Parasitology 1981; 83: 253-8.
19. Han JK, Choi BI, Cho JM, et al. Radiological findings of human fascioliasis. Abdom Imaging 1993; 18: 261-4.
20. Price TA, Tuazon CU, Simon GL. Fascioliasis: case reports and review. Clin Infec Dis 1993; 17: 426-30.
21. Han JK, Han D, Choi BI, Han MC. MR findings in human fascioliasis. Trop Med Int Health 1996; 1: 367-72.
22. Carroll BA, Oppenheimer DA. Sclerosing cholangitis: sonographic demonstration of bile duct wall thickening. Am J Roentgenol 1982; 139: 1016-8.
23. Teefey SA, Baron RL, Rohrmann CA, et al. Sclerosing cholangitis: CT findings. Radiology 1988; 169: 635-9.
24. Dolmatch BL, Laing FC, Federle MP, et al. AIDS-related cholangitis: radiographic findings in nine patients. Radiology 1987; 163: 313-6.
25. Ooms HWA, Puylaert JBCM, van der Werf SDJ. Biliary fascioliasis: US and endoscopic retrograde cholangiopancreatography findings. Eur Radiol 1995; 5: 196-9.
26. Acosta-Ferreira W, Vercelli-Retta J, Falconi LM. Fasciola hepatica human infection. Histopathological study of sixteen cases. Virchows Arch A Pathol Anat Hist 1979; 383: 319-27.
27. Condomines J, Rene-Espinet JM, Espinoz-Perez JC, Vilardell F. Percutaneous cholangiography in the diagnosis of hepatic fascioliasis. Am J Gastroenterol 1985; 80: 384-6.
28. Hauser SC, Bynum TE. Abnormalities on ERCP in a case of human fascioliasis. Gastrointest Endos 1984; 30: 80-2.
29. Stitt AW, Fairweather I. The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica. Parasitology 1994; 108: 555-67.
30. Stitt AW, Fairweather I, Mackender RO. The effect of triclabendazole ('Fasinex') on protein synthesis by the liver fluke, Fasciola hepatica. Int J Parasit 1995; 25: 421-9.
31. Stitt AW, Fairweather I. Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole. Parasitol Res 1996; 82: 333-9.
32. Bacq Y, Besnier JM, Duong TH, et al. Successful treatment of acute fascioliasis with bithionol. Hepatology 1991; 14: 1066-9.
33. Cosme A, Ojeda E, Cilia G, et al. Fasciola hepatica. Study of series of 37 patients. Gastroenterol Hepatol 2001; 24: 375-80.
34. Hawn TR, Jong EC. Update on hepatobiliary and pulmonary flukes. Curr Infec Dis Rep 1999; 1: 427-33.
35. Hardman EW, Jones RLH, Davies AH. Fascioliasis-a large outbreak. Br Med J 1970; 3: 979-83.